Campus News Banner


Faculty to Be Hired in Medical Center

Contact: Ralph Derickson

""

The UK colleges of Dentistry, Nursing and Pharmacy as well as the UK Markey Cancer Center and Graduate Program Center in Toxicology will each hire one new faculty member under this program. The UK College of Medicine will hire four new faculty. The nine faculty hired under this initiative will conduct research in a wide range of fields, including epidemiology, cardiovascular research, pharmacogenomics, DNA damage, Alzheimer’s disease, neuroscience, and microbiology.

""

LEXINGTON, Ky. (Nov. 4, 2003) -- A second round of investments in new faculty positions recommended by a University of Kentucky Futures Committee appointed by Provost Michael T. Nietzel will result in the hiring of nine new faculty members in colleges and centers in the UK Chandler Medical Center.

Recommendations from the Futures Committee led Provost Nietzel to make investments in the non-medical colleges during the last fiscal year. The most recent round of investments extends the process to the Chandler Medical Center and supports the university’s Strategic Plan, “The Dream and the Challenge,” recently presented by President Lee T. Todd Jr. and approved by the UK Board of Trustees.

The UK colleges of Dentistry, Nursing and Pharmacy as well as the UK Markey Cancer Center and Graduate Program Center in Toxicology will each hire one new faculty member under this program. The UK College of Medicine will hire four new faculty. The nine faculty hired under this initiative will conduct research in a wide range of fields, including epidemiology, cardiovascular research, pharmacogenomics, DNA damage, Alzheimer’s disease, neuroscience, and microbiology.

“Each of the new faculty will join a growing team of investigators who will bring modern research techniques to bear on various diseases that afflict Kentuckians,” Nietzel said.

The UK College of Pharmacy, for example, plans to hire a new faculty member who will study novel approaches to cancer research in the area of pharmacogenomics. Pharmacogenomics is the study of how genes affect the way people respond to medicines, including those used to treat cancer and a variety of other disorders.

This research and its application in clinical practice will provide safe, effective medications for individuals who share a particular commonality in their genetic profile. Cancer has a significant economic and social impact in Kentucky, and the nationally ranked UK College of Pharmacy and UK Markey Cancer Center are developing an Experimental Therapeutics Program with research in this field as a central element.

Each of the faculty hired under this program will be identified through a national search process and will join the faculty sometime in 2004.

“I am delighted that we are able to make this investment and confident that these new faculty will contribute to the university’s growing national reputation and ranking,” Nietzel said.


Back to Campus News Homepage